The USDT-settled contract uses Novo Nordisk (NVO) as its underlying asset and is live for manual trading and Bybit's Futures Grid, Futures Martingale and Futures Combo bots.
Bybit has opened trading in the NVOUSDT Perpetual Contract, a USDT-settled perpetual contract (futures without expiry) with Novo Nordisk (NVO) as the underlying asset, offering up to 25x leverage. The product is available for direct trading and through Bybit's Futures bots, including Futures Grid, Futures Martingale and Futures Combo. The exchange lists a tick size of 0.01, a capped funding rate (periodic payment balancing contract prices) of 2%, funding fee settlement every 8 hours and 24/7 trading. Bybit also said it may adjust the launch time and contract settings, including price increments, leverage, margin rates, order size limits and mark and index price calculations.